Good news about the treatment of Alzheimer’s disease is hard to find. However, new breakthrough research is hailed as the “best news” in dementia research for 25 years and a potential “game changer” for people with the disease. In a preliminary trial a bioengineered medication called aducanumab has demonstrated the ability to clear accumulations of beta-amyloid proteins—a hallmark of Alzheimer’s—from the brain. Compared with subjects receiving a placebo medication, those who got monthly infusions of aducanumab in high doses appeared to experience less progressive loss in mental function.
Experimental drug slows memory loss and halts Alzheimer’s decline
More of Today's Solutions
Here are some easy recipes for making your own hand sanitizer
By now you must surely be aware that washing your hands clean is necessary to keep you and others protected during the pandemic. You’ve ...
Read MoreThe case for shifting to a four-day workweek for post-pandemic life
At The Optimist Daily, we’re putting a lot of focus on what the world can do after the pandemic to create a healthier, more ...
Read MoreSo your compost has mold? What it means and what to do about it
So you’ve set up a functioning compost system in your backyard. First things first, congratulations! But how do you know if your compost is ...
Read MoreMapping out the Milky Way’s snacks gives clues into dark matter
In our galaxy’s galactic halo, there are 12 streams of stars orbiting. These burning balls of gas are actually being torn apart and their ...
Read More
